Mov Disord Vol 34, Suppl 2 Archives - Page 166 of 217 - MDS Abstracts

2019 International Congress
Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies
D. Hansen, T. Lashley, J. Holton, T. Warner (London, United Kingdom)
Objective: To compare motor and neuropathological features of Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) and to determine clinical and neuropathological differences…
2019 International Congress
Visual dysfunction and retinal thinning predict dementia risk in Parkinson’s disease
L-A. Leyland, F. Bremner, R. Mahmood, S. Hewitt, M. Durteste, M. Cartlidge, M. Lai, L. Miller, A. Saygin, P. Keane, A. Schrag, R. Weil (London, United Kingdom)
Objective: We assessed the role of visual measures and retinal volume (in dopaminergic layers: ganglion cell layer (GCL) and inner plexiform layer (IPL)) to predict…
2019 International Congress
Clinical, motor and global cognition in patients with in early stages of Parkinson disease
J. Orozco, J. Valderrama, Y. Castaño, J. Arango, A. Navarro, B. Muñoz (Cali, Colombia)
Objective: To explore if balance and freezing of gait correlate with global cognition in patients with Parkinson disease in early stages. Background: Early alterations in…
2019 International Congress
Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil
N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)
Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…
2019 International Congress
Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.
F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)
Objective: To evaluate whether type 2 diabetes at baseline is a risk factor for Parkinson's disease. Background: Parkinson’s disease is a chronic disorder in which…
2019 International Congress
The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study
J. Kauffmann, M. Unger, G. Giebel, D. Grün, K. Faßbender, M. Fousse (Homburg, Germany)
Objective: To elucidate the role of neuroendocrine hormones in Parkinson’s disease (PD) and evaluate their potential utilization as biomarkers. Background: A growing body of evidence,…
2019 International Congress
Alpha-synuclein interacts with BAF complex in nucleus
N. Sugeno, T. Hasegawa, J. Kobayashi, S. Yoshida, M. Ezura, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)
Objective: This study aims to uncover the prospective partner of αS in nucleus. Background: In neuronal cells, large part of alpha-synuclein (αS) localize at presynaptic…
2019 International Congress
Association of active and passive smoking with Parkinson’s disease in women: the E3N cohort study
M. Canonico, F. Artaud, D. Cerasuolo, I. Degaey, P. Gerbouin-Rerolle, A. Kowal, E. Roze, G. Severi, MC. Boutron-Ruault, A. Elbaz (Villejuif, France)
Objective: To investigate the association of active and passive smoking with Parkinson’s disease (PD) incidence in women over 25y of follow-up. Background: PD is the…
2019 International Congress
Associations of gait disorders and future falls in the elderly: a prospective population-based study
K. Marini, P. Mahlknecht, O. Schorr, M. Baumgartner, A. Djamshidian, A. Gasperi, S. Kiechl, G. Rungger, H. Stockner, J. Willeit, W. Poewe, K. Seppi (Innsbruck, Austria)
Objective: The aim of this prospective study was to investigate the association of gait disorders (GDs) and quantitative gait measures with future falls in an…
2019 International Congress
Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre.
T. Schirinzi, G. Di Lazzaro, M. Pierantozzi, A. Stefani, N. Mercuri, A. Pisani (Rome, Italy)
Objective: To provide descriptive data on clinical features and therapy of older patients with PD (OPD) from an Italian single centre. Background: The incidence of…